PRESS-RELEASE filed Jul 27, 2026 at 14:52 ET
Royal Philips reported Q2 2026 comparable sales growth of 4% to EUR 4.4B, with Adjusted EBITA margin expanding to 16.4% (including a ~4.2% US tariff refund benefit). The company raised its full-year Adjusted EBITA margin guidance to 13.5%-14.0% (from 12.5%-13.0%) and free cash flow guidance to EUR 1.5-1.7B (from EUR 1.3-1.5B), both reflecting the tariff refund. However, comparable order intake declined 1% due to timing of large Connected Care orders shifting to Q3, and excluding the tariff refund, Adjusted EBITA slightly decreased on cost inflation and higher tariffs, making the underlying operational picture mixed.